Ajay Verma is a neurologist, neuroscientist, drug developer, inventor and biotech science advisor. He was most recently the Head of R&D at Yumanity Therapeutics. He has also served as EVP of Research and Experimental Medicine at Codiak Biosciences, CMO at United Neuroscience, VP of Neurology at Biogen and Novartis, and Director of Neuroscience Experimental Medicine at Merck. Ajay's drug development experience spans small molecule, peptide/protein, antibody, oligonucleotide, vaccine and exosome drug platforms given via multiple dosing routes. He has largely focused on translational and early clinical development in neurology indications using precision drug development approaches that leverage biomarkers and experimental medicine paradigms. Ajay is also highly engaged in advancing CNS drug development sciences and has developed novel inventions and experimental medicine approaches for assessing disease process and drug effects. He is a scientific advisor to several biomarker, CRO and biotech companies, a Visiting Adjunct Professor at U of Southampton and U of Rhode Island and an Independent Review Committee member for Target ALS. Prior to Biopharma, Ajay was a U.S. Army Lt. Colonel and Professor of Neurology at the Uniformed Services University of the Health Sciences and staff neurologist at the Walter Reed Army Medical Center. Ajay received his M.D. and Ph.D. degrees from Johns Hopkins University, where he trained in the laboratory of Dr. Solomon H. Snyder.